News from aeterna zentaris inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Dec 19, 2014, 09:00 ET

Aeterna Zentaris Receives Notification from NASDAQ Relating to Minimum Bid Price

QUEBEC CITY, Dec. 19, 2014 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS; TSX: AEZ) (the "Company") announced today that it has...

Dec 01, 2014, 07:30 ET

Aeterna Zentaris and Sinopharm A-Think Sign Master Collaboration Agreement for Zoptarelin Doxorubicin in China

All amounts are in U.S. dollars QUÉBEC CITY, Dec. 1, 2014 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") and...

Nov 20, 2014, 07:30 ET

Aeterna Zentaris Adds Hollings Cancer Center to Multi-National Phase 3 Trial in Endometrial Cancer

Patient recruitment in line to secure expected interim analysis in H1 2015 All amounts are in U.S. dollars (unless otherwise noted) QUÉBEC...

Nov 06, 2014, 07:00 ET

FDA Issues Complete Response Letter for Aeterna Zentaris' Macrilen™ NDA in Adult Growth Hormone Deficiency

QUÉBEC CITY, Nov. 6, 2014 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS, TSX: AEZ) (the "Company") today announced that the Company...

Nov 04, 2014, 16:30 ET

Aeterna Zentaris Reports Third Quarter 2014 Financial and Operating Results

All amounts are in US dollars QUEBEC CITY, Nov. 4, 2014 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company"), a...

Oct 28, 2014, 07:30 ET

Aeterna Zentaris to Announce Third Quarter 2014 Financial and Operating Results on November 4, 2014

QUEBEC CITY, Oct. 28, 2014 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") will announce its third quarter...

Oct 27, 2014, 07:30 ET

Aeterna Zentaris Announces Formal Implementation of its Sales Force In Support of Selling ASCEND's EstroGel®

QUÉBEC CITY, Oct. 27, 2014 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") today announced the formal...

Oct 07, 2014, 07:30 ET

Aeterna Zentaris Appoints Phil Theodore as Chief Administrative Officer, General Counsel and Corporate Secretary

QUÉBEC CITY, Oct. 7, 2014 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") today announced the...

Sep 02, 2014, 16:15 ET

Aeterna Zentaris to Present at Upcoming Rodman & Renshaw Annual Global Investment Conference in New York

QUÉBEC CITY, Sept. 2, 2014 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") today announced that the...

Aug 07, 2014, 16:30 ET

Aeterna Zentaris Reports Second Quarter 2014 Financial and Operating Results

All amounts are in US dollars QUEBEC CITY, Aug. 7, 2014 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company"), a...

Aug 06, 2014, 07:30 ET

Aeterna Zentaris to Present at Upcoming Canaccord Genuity 34th Annual Global Growth Conference in Boston

QUÉBEC CITY, Aug. 6, 2014 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") today announced that the...

Aug 05, 2014, 07:30 ET

Aeterna Zentaris and ASCEND Therapeutics Sign Co-Promotion Agreement for U.S. Market

QUÉBEC CITY, Aug. 5, 2014 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") today announced a strategic...

Jun 10, 2014, 07:30 ET

Aeterna Zentaris Implements Global Resources Optimization Program as Part of its Transition into a Commercially Operating Specialty Biopharmaceutical Company

QUÉBEC CITY, June 10, 2014 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") today announced the...

Jun 02, 2014, 07:30 ET

Aeterna Zentaris: Poster Presented at ASCO Meeting on the Design of the Current ZoptEC Phase 3 Trial in Endometrial Cancer

QUEBEC CITY, June 2, 2014 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") today announced that a poster was...

May 22, 2014, 07:30 ET

Aeterna Zentaris: Poster to be Presented on the Design of Current ZoptEC Phase 3 Trial in Endometrial Cancer with Zoptarelin Doxorubicin at ASCO

QUÉBEC CITY, May 22, 2014 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS, TSX: AEZ) (the "Company") today announced that a poster...

May 12, 2014, 07:30 ET

Aeterna Zentaris Announces Board of Directors Leadership Change and Election of Directors at Annual Meeting of Shareholders

QUÉBEC CITY, May 12, 2014 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") announces that following...

May 09, 2014, 16:15 ET

Aeterna Zentaris Announces At the Market Issuance Program

QUEBEC CITY, May 9, 2014 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") announced today that it has...

May 08, 2014, 16:30 ET

Aeterna Zentaris Reports First Quarter 2014 Financial and Operating Results

All amounts are in US dollars QUEBEC CITY, May 8, 2014 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company"), a...

May 05, 2014, 07:30 ET

Aeterna Zentaris Selects Charleston, S.C. as New Location for its North American Business and Global Commercial Operations

QUÉBEC CITY, May 5, 2014 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company"), a specialty biopharmaceutical...

Apr 30, 2014, 07:30 ET

Aeterna Zentaris to Announce First Quarter 2014 Financial and Operating Results on May 8, 2014 and Hold Annual Shareholders Meeting on May 9, 2014

QUEBEC CITY, April 30, 2014 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") will announce its first...